Science

Israel is home to close to 200 startups and companies with wide-ranging solutions to offer in the battle against the disease, not to mention the dozens of scientific initiatives.

The round will enable Scopio Labs to expand commercial operations across human and veterinary care in the United States and Europe,

In the offices of Jerusalem Venture Partners, employees must undergo a set of measures to ensure they don't have symptoms of COVID-19 and are fit to work.

The Vancouver-based company, co-founded by an Israeli scientist, developed a patented platform for the topical delivery of nitric oxide to treat a variety of bacterial, fungal, and viral diseases.

Maccabi Healthcare Services is using Medial EarlySign's AI system to identify which members are high-risk once they develop symptoms for the novel coronavirus.

InnovoPro is targeting an over $40 billion market of protein ingredients and is aiming to expand and identify partners to launch the next generation factory for chickpea protein production.

The new company, MigVax, is an affiliate of The Migal Galilee Research Institute and will pioneer the effort to develop the vaccine.

Tel Aviv University's Professor Jonathan Gershoni has been working on coronaviruses for the last 15 years and his method could serve as a basis for a COVID-19 vaccine.

The Israeli CBD therapeutics company will partner with the university's technology transfer arm to develop a novel approach to COVID-19 treatment using CBD-loaded exosomes.

The Israel Innovation Authority issued a call for companies to submit proposals to be part of the lab.

After 5 weeks of isolation and closures, Israel is starting to think about how to emerge from the crisis.

Hebrew University researchers say their method relies on an existing process to extract genetic material using magnetic beads but uses a special buffer solution to accelerate and ameliorate binding.

The US company that develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons will acquire the US-Israeli medical device firm for shares and $2 million in cash.

Weizmann Institute, TAU to help process samples as authorities aim to increase daily testing to up to 30,000.

Founded in 2015, Datos developed a hospital-grade remote care platform that offers a fully automated approach to patient care and data handling.